      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04523987",
            "orgStudyIdInfo": {
              "id": "PA02/07/18"
            },
            "organization": {
              "fullName": "National University Hospital, Singapore",
              "class": "OTHER"
            },
            "briefTitle": "A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.",
            "officialTitle": "A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma."
          },
          "statusModule": {
            "statusVerifiedDate": "2020-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
              "hasExpandedAccess": false
            },
            "startDateStruct": {
              "date": "2019-02-22",
              "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
              "date": "2023-02",
              "type": "ESTIMATED"
            },
            "completionDateStruct": {
              "date": "2024-02",
              "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-08-19",
            "studyFirstSubmitQcDate": "2020-08-19",
            "studyFirstPostDateStruct": {
              "date": "2020-08-24",
              "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2020-08-19",
            "lastUpdatePostDateStruct": {
              "date": "2020-08-24",
              "type": "ACTUAL"
            }
          },
          "sponsorCollaboratorsModule": {
            "responsibleParty": {
              "type": "SPONSOR"
            },
            "leadSponsor": {
              "name": "National University Hospital, Singapore",
              "class": "OTHER"
            }
          },
          "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
          },
          "descriptionModule": {
            "briefSummary": "This is a single-center, pilot study evaluating the addition of Ciprofloxacin (study drug) to standard-of-care gemcitabine and nab-paclitaxel chemotherapy in treatment-naïve metastatic PDAC patients. Patients who are recommended gemcitabine and nab-paclitaxel chemotherapy as a standard-of-care by their treating physician will be offered to participate in this study.",
            "detailedDescription": "Oral ciprofloxacin (study drug) will be administered twice a day throughout each 28-day cycle of gemcitabine and nab-paclitaxel chemotherapy. The patient will start taking ciprofloxacin from the evening of day 1 of chemotherapy and end on the morning of day 29 of each cycle.\n\nCiprofloxacin tablets should be taken in the morning and evening at about the same time each day. Swallow the tablet whole. Do not split, crush or chew the tablet. Ciprofloxacin can be taken with or without food\n\nWith each study visit, the physician will prescribe 1-month supply of oral ciprofloxacin to be taken home and self-administered by the patient. The physician will have to indicate \"pancreatic cancer microbiome study\" on the remarks column for each cycle oral ciprofloxacin is ordered."
          },
          "conditionsModule": {
            "conditions": [
              "Metastatic Pancreatic Ductal Adenocarcinoma"
            ],
            "keywords": [
              "Ciprofloxacin",
              "Gemcitabine",
              "Nab-Paclitaxel Chemotherapy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
              "PHASE1"
            ],
            "designInfo": {
              "allocation": "NA",
              "interventionModel": "SINGLE_GROUP",
              "interventionModelDescription": "This is a single-center, pilot study evaluating the addition of Ciprofloxacin (study drug) to standard-of-care gemcitabine and nab-paclitaxel chemotherapy in treatment-naïve metastatic PDAC patients.",
              "primaryPurpose": "TREATMENT",
              "maskingInfo": {
                "masking": "NONE"
              }
            },
            "enrollmentInfo": {
              "count": 10,
              "type": "ESTIMATED"
            }
          },
          "armsInterventionsModule": {
            "armGroups": [
              {
                "label": "gemcitabine and nab-paclitaxel chemotherapy",
                "type": "EXPERIMENTAL",
                "description": "Patients who are recommended gemcitabine and nab-paclitaxel chemotherapy as a standard-of-care by their treating physician will be offered to participate in this study.",
                "interventionNames": [
                  "Drug: Ciprofloxacin"
                ]
              }
            ],
            "interventions": [
              {
                "type": "DRUG",
                "name": "Ciprofloxacin",
                "description": "Subjects enrolled will be administered oral ciprofloxacin twice a day throughout the course of each 28-day cycle of gemcitabine and nab-paclitaxel chemotherapy.",
                "armGroupLabels": [
                  "gemcitabine and nab-paclitaxel chemotherapy"
                ]
              }
            ]
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Antitumor Effect - Solid Tumors",
                "description": "Patients are be re-evaluated for response every 8-12 weeks (±10 days), per standard-of-care.\n\nResponse and progression will be evaluated in this study using the international criteria proposed by the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1). Changes in the largest diameter (unidimensional measurement) of the tumor lesions and the shortest diameter in the case of malignant lymph nodes are used in RECIST.",
                "timeFrame": "4 years"
              }
            ]
          },
          "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Signed informed consent. Written informed consent must be obtained prior to performing any study-related procedures.\n* Age ≥ 21 years\n* Histologically or cytologically confirmed, treatment-naïve, locally advanced or metastatic pancreatic adenocarcinoma planned to commence on gemcitabine and nab-paclitaxel chemotherapy.\n* Patient must have measurable disease as defined by the Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v 1.1 guidelines)\n* Life expectancy \\>3 months\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2\n* CrCl ≥ 30 ml/min\n\nExclusion Criteria:\n\n* Known hypersensitivity or allergy to ciprofloxacin or other quinolones\n* On tizanidine or theophylline and unable to stop these medication\n* Known QTc prolongation (QTc \\>500 msec) or torsade de pointes\n* Presence of Clostridium difficile-associated diarrhea or colitis\n* Known history of myasthenia gravis\n* Known G6PD deficiency",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "21 Years",
            "maximumAge": "99 Years",
            "stdAges": [
              "ADULT",
              "OLDER_ADULT"
            ]
          },
          "contactsLocationsModule": {
            "centralContacts": [
              {
                "name": "Cheng Ean Chee",
                "role": "CONTACT",
                "phone": "6779 5555",
                "email": "cheng_ean_chee@nuhs.edu.sg"
              }
            ],
            "overallOfficials": [
              {
                "name": "Cheng Ean Chee",
                "affiliation": "cheng_ean_chee@nuhs.edu.sg",
                "role": "PRINCIPAL_INVESTIGATOR"
              }
            ],
            "locations": [
              {
                "facility": "National University Hospital",
                "status": "RECRUITING",
                "city": "Singapore",
                "country": "Singapore",
                "contacts": [
                  {
                    "name": "Cheng Ean Chee",
                    "role": "CONTACT",
                    "phone": "779 5555",
                    "email": "cheng_ean_chee@nuhs.edu.sg"
                  }
                ],
                "geoPoint": {
                  "lat": 1.28967,
                  "lon": 103.85007
                }
              }
            ]
          },
          "referencesModule": {
            "references": [
              {
                "pmid": "28348497",
                "type": "RESULT",
                "citation": "Ertz-Archambault N, Keim P, Von Hoff D. Microbiome and pancreatic cancer: A comprehensive topic review of literature. World J Gastroenterol. 2017 Mar 14;23(10):1899-1908. doi: 10.3748/wjg.v23.i10.1899."
              },
              {
                "pmid": "21994333",
                "type": "RESULT",
                "citation": "Farrell JJ, Zhang L, Zhou H, Chia D, Elashoff D, Akin D, Paster BJ, Joshipura K, Wong DT. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012 Apr;61(4):582-8. doi: 10.1136/gutjnl-2011-300784. Epub 2011 Oct 12."
              }
            ]
          }
        },
        "derivedSection": {
          "miscInfoModule": {
            "versionHolder": "2023-12-08",
            "modelPredictions": {
              "bmiLimits": {
                "minBmi": 0,
                "maxBmi": 101
              }
            }
          },
          "conditionBrowseModule": {
            "meshes": [
              {
                "id": "D000000230",
                "term": "Adenocarcinoma"
              }
            ],
            "ancestors": [
              {
                "id": "D000002277",
                "term": "Carcinoma"
              },
              {
                "id": "D000009375",
                "term": "Neoplasms, Glandular and Epithelial"
              },
              {
                "id": "D000009370",
                "term": "Neoplasms by Histologic Type"
              },
              {
                "id": "D000009369",
                "term": "Neoplasms"
              }
            ],
            "browseLeaves": [
              {
                "id": "M3275",
                "name": "Adenocarcinoma",
                "asFound": "Adenocarcinoma",
                "relevance": "HIGH"
              },
              {
                "id": "M5224",
                "name": "Carcinoma",
                "relevance": "LOW"
              },
              {
                "id": "M12010",
                "name": "Neoplasms, Glandular and Epithelial",
                "relevance": "LOW"
              },
              {
                "id": "M12005",
                "name": "Neoplasms by Histologic Type",
                "relevance": "LOW"
              }
            ],
            "browseBranches": [
              {
                "abbrev": "BC04",
                "name": "Neoplasms"
              },
              {
                "abbrev": "All",
                "name": "All Conditions"
              }
            ]
          },
          "interventionBrowseModule": {
            "meshes": [
              {
                "id": "D000002939",
                "term": "Ciprofloxacin"
              }
            ],
            "ancestors": [
              {
                "id": "D000000900",
                "term": "Anti-Bacterial Agents"
              },
              {
                "id": "D000000890",
                "term": "Anti-Infective Agents"
              },
              {
                "id": "D000059005",
                "term": "Topoisomerase II Inhibitors"
              },
              {
                "id": "D000059003",
                "term": "Topoisomerase Inhibitors"
              },
              {
                "id": "D000004791",
                "term": "Enzyme Inhibitors"
              },
              {
                "id": "D000045504",
                "term": "Molecular Mechanisms of Pharmacological Action"
              },
              {
                "id": "D000000970",
                "term": "Antineoplastic Agents"
              },
              {
                "id": "D000065609",
                "term": "Cytochrome P-450 CYP1A2 Inhibitors"
              },
              {
                "id": "D000065607",
                "term": "Cytochrome P-450 Enzyme Inhibitors"
              }
            ],
            "browseLeaves": [
              {
                "id": "M19227",
                "name": "Paclitaxel",
                "relevance": "LOW"
              },
              {
                "id": "M2986",
                "name": "Gemcitabine",
                "relevance": "LOW"
              },
              {
                "id": "M5866",
                "name": "Ciprofloxacin",
                "asFound": "Sequential",
                "relevance": "HIGH"
              },
              {
                "id": "M231",
                "name": "Albumin-Bound Paclitaxel",
                "relevance": "LOW"
              },
              {
                "id": "M3912",
                "name": "Anti-Bacterial Agents",
                "relevance": "LOW"
              },
              {
                "id": "M3904",
                "name": "Anti-Infective Agents",
                "relevance": "LOW"
              },
              {
                "id": "M7641",
                "name": "Enzyme Inhibitors",
                "relevance": "LOW"
              },
              {
                "id": "M30227",
                "name": "Cytochrome P-450 Enzyme Inhibitors",
                "relevance": "LOW"
              }
            ],
            "browseBranches": [
              {
                "abbrev": "ANeo",
                "name": "Antineoplastic Agents"
              },
              {
                "abbrev": "All",
                "name": "All Drugs and Chemicals"
              },
              {
                "abbrev": "Infe",
                "name": "Anti-Infective Agents"
              }
            ]
          }
        },
        "hasResults": false
      }


